Lancet Neurology
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
Application of diagnostic criteria for optic neuritis - Authors' reply.
22:376-377.
2023-01-01
-
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
22:268-282.
2023-01-01
-
The polypill from a public-health perspective.
22:294-295.
2023-01-01
-
Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort study.
21:1-449.
2022-01-01
-
Diagnosis and classification of optic neuritis.
1:1-15.
2022-01-01
-
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
21:1110-1119.
2022-01-01
-
The reality of multiple sclerosis assessment in middle-income countries.
21:215-215.
2022-01-01
-
Epilepsy care in China and its relevance for other countries.
20:333-334.
2021-01-01
-
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
1:1-820.
2021-01-01
-
Intracranial pressure monitoring and unfavourable outcomes.
20:978-979.
2021-01-01
-
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
20:49-59.
2021-01-01
-
Myelin-oligodendrocyte glycoprotein antibody-associated disease.
20:762-772.
2021-01-01
-
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
20:1012-1026.
2021-01-01
-
Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia.
19:784-796.
2020-01-01
-
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
19:422-433.
2020-01-01
-
Covid-19 in older people with cognitive impairment in Latin America.
19:719-721.
2020-01-01
-
Global prevention of stroke and dementia: the WSO Declaration.
19:487-488.
2020-01-01
-
Living without the opioid epidemic: how far have we come?.
19:16-17.
2020-01-01
-
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
1:1-10.
2020-01-01
-
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
19:573-581.
2020-01-01
-
Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study.
19:826-839.
2020-01-01
-
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
19:226-233.
2020-01-01
tem uma área de assunto
publisher
is open access
-
False
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S70053155
International Standard Serial Number (ISSN)